News Minimalist logo

GLP-1 drugs reduce cancer risks for diabetes patients

Finimize — July 5, 2024, 05:00 PM UTC

Summary: A study reveals that diabetes patients on GLP-1 drugs, like Ozempic, have lower risks of 10 obesity-related cancers. GLP-1 therapies, including Ozempic and Mounjaro, have shown significant benefits for blood sugar control and weight loss. The study, analyzing 1.6 million patients, was published on July 5, 2024, in JAMA Network Open. Novo Nordisk and Eli Lilly are experiencing increased profits due to the popularity of these treatments.

Full article

Article metrics

The article metrics are deprecated.

I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.

Timeline:

  1. [3.2]
    Weight loss drugs may enhance brain health in diabetes (Gizmodo)
    57d 6h
    Source
  2. [4.5]
    GLP-1 drugs offer benefits beyond obesity and diabetes (News-Medical.Net)
    57d 12h
    Source
  3. [3.3]
    Dr. Daniel Drucker discusses future of Ozempic-like drugs (New York Post )
    62d 4h
    Source
  4. [4.0]
    Semaglutide not linked to higher neuropsychiatric risks in T2DM (News-Medical.Net)
    63d 12h
    Source
  5. [2.7]
    Oral semaglutide matches DPP-4i in T2D adherence, persistence (News-Medical.Net)
    64d 19h
    Source
  6. [4.6]
    Ozempic linked to cognitive benefits in diabetes patients (PMLiVE)
    65d 11h
    Source
  7. [3.2]
    AI analysis of Reddit shows interest in GLP-1 drugs for weight loss and mental health benefits (News-Medical.Net)
    65d 21h
    Source
  8. [2.5]
    Semaglutide may pose risk of vision loss: Study urges caution (Business Standard)
    66d 18h
    Source
  9. [4.7]
    Ozempic improves heart and kidney health for diabetes patients (Sydney Morning Herald)
    67d 14h
    Source
  10. [4.9]
    Semaglutide (Ozempic) may reduce dementia risk and nicotine cravings (Neuroscience News)
    68d 2h
    Source
  11. [3.2]
    Ozempic linked to lower dementia risk, nicotine use - study (The Straits Times)
    68d 5h
    Source
  12. [3.2]
    Ozempic linked to lower dementia risk, nicotine use in study (The Globe and Mail)
    68d 5h
    Source
  13. [3.9]
    Antidiabetic drugs linked to lower dementia risk in T2DM (News-Medical.Net)
    68d 6h
    Source
  14. [4.0]
    Ozempic linked to lower dementia rate in Oxford study (BNN Bloomberg)
    68d 14h
    Source
  15. [3.5]
    Ozempic and similar drugs may lower cancer risks (Forbes Australia)
    68d 19h
    Source
  16. [3.3]
    GLP-1 agonists lower dementia risk for diabetes patients (PsyPost)
    68d 22h
    Source
  17. [3.9]
    Weight-loss jabs lower cancer risk compared to insulin - study (The Conversation)
    69d 7h
    Source
  18. [4.7]
    GLP-1 agonists reduce cancer risk in type 2 diabetes (Inside Precision Medicine)
    70d 7h
    Source
  19. [3.4]
    GLP-1s reduce cancer risk in type 2 diabetes patients (PMLiVE)
    70d 11h
    Source
  20. [3.9]
    GLP-1 drugs linked to lower cancer risks in diabetes patients (Ars Technica)
    71d 7h
    Source
  21. [3.5]
    Semaglutide linked to rare eye disease causing vision loss (ScienceAlert)
    71d 12h
    Source
  22. [2.2]
    Semaglutide linked to higher risk of NAION in study (The Express Tribune)
    72d 10h
    Source
  23. [2.5]
    Semaglutide (Ozempic) linked to increased risk of blindness (Insight)
    72d 19h
    Source
  24. [5.5]
    GLP-1 agonists like Ozempic lower cancer risks in study (ScienceAlert)
    72d 20h

    ScoresSource
  25. [5.3]
    GLP-1 meds like Ozempic, Wegovy may lower cancer risk (CTV News)
    73d 9h

    ScoresSource
  26. [4.4]
    GLP-1 diabetes drugs reduce cancer risk, study finds (The Manila Times)
    74d 7h
    Source
  27. [5.0]
    GLP-1 medications may lower risk of certain cancers (CNN)
    74d 22h

    ScoresSource
  28. [2.2]
    GLP-1s lower risk of 10 obesity-related cancers in diabetes (Medpage Today)
    75d 2h
    Source
  29. [5.2]
    GLP-1 drugs like Ozempic may reduce cancer risk (Quartz)
    75d 3h

    ScoresSource
  30. [5.1]
    GLP-1 treatments reduce cancer risk in diabetes patients (GMA News Online)
    75d 4h

    ScoresSource
  31. [1.3]
    Weight loss drugs linked to rare eye condition risk (India TV News)
    75d 19h
    Source
  32. [2.9]
    Weight-loss drugs may increase risk of rare blindness (Firstpost)
    76d 11h
    Source
  33. [3.2]
    Novo Nordisk weight loss drugs linked to rare eye condition (CNBC)
    76d 13h
    Source
  34. [3.3]
    Ozempic linked to rare blindness cases in study (Business Insider)
    77d 5h
    Source
  35. [3.2]
    Wegovy, Ozempic linked to sight-threatening eye disorder in study (GMA News Online)
    77d 7h
    Source
  36. [3.4]
    Weight loss and diabetes drugs linked to rare blindness risk (CNN)
    77d 8h
    Source
  37. [3.2]
    Weight-loss jabs linked to potential blindness risk in study (The Guardian)
    77d 8h
    Source